ARROWHEAD PHARMACEUTICALS, INC.: 10-Q filed 2016-02-09

Name: ARROWHEAD PHARMACEUTICALS, INC.: 10-Q filed 2016-02-09
Creator: ARROWHEAD PHARMACEUTICALS, INC.

What ARROWHEAD PHARMACEUTICALS, INC. reported in its quarterly report filed 2016-02-09 (fiscal Q1 2016): 33 published measures, 67 facts as tagged in accession 0001564590-16-012515.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-02-09
Fiscal period: fiscal Q1 2016
Accession: 0001564590-16-012515 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARROWHEAD PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-12-31	111,381,139	USD
At 2015-09-30	132,267,914	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-12-31	92,923,580	USD
At 2015-09-30	110,176,822	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-12-31	62,165,088	USD
At 2015-09-30	81,214,354	USD
At 2014-12-31	103,991,231	USD
At 2014-09-30	132,510,610	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-19,264,414	USD	92
2014-10-01 to 2014-12-31	-22,575,282	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	406,612	USD	92
2014-10-01 to 2014-12-31	554,945	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	43,750	USD	92
2014-10-01 to 2014-12-31	170,750	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-12-31	-335,976,455	USD
At 2015-09-30	-316,712,041	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-12-31	4,666,411	USD
At 2015-09-30	4,526,848	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	2,380,343	USD	92
2014-10-01 to 2014-12-31	2,014,856	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-19,341,270	USD	92
2014-10-01 to 2014-12-31	-25,115,276	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-12-31	82,283,814	USD
At 2015-09-30	102,871,161	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-12-31	12,328,014	USD
At 2015-09-30	15,900,571	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-12-31	5,288,922	USD
At 2015-09-30	5,031,706	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2015-12-31	23,440,190	USD
At 2015-09-30	23,879,181	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	19,385,020	USD	92
2014-10-01 to 2014-12-31	25,286,026	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-12-31	59,627,499	shares
At 2015-09-30	59,544,677	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-12-31	428,838,629	USD
At 2015-09-30	426,873,358	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-12-31	-90,607	USD
At 2015-09-30	-136,425	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2015-12-31	92,368,392	USD
At 2015-09-30	109,621,634	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-12-31	10,474,877	USD
At 2015-09-30	9,987,513	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-12-31	5,808,466	USD
At 2015-09-30	5,460,665	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-12-31	24,385,125	USD
At 2015-09-30	24,824,116	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-12-31	45,789	USD
At 2015-09-30	45,789	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-12-31	336,427	USD
At 2015-09-30	342,453	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-12-31	3,920,312	USD
At 2015-09-30	5,376,119	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-19,264,414	USD	92
2014-10-01 to 2014-12-31	-22,575,282	USD	92

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-19,264,414	USD	92
2014-10-01 to 2014-12-31	-22,575,282	USD	92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-19,218,596	USD	92
2014-10-01 to 2014-12-31	-22,575,282	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	1,951,609	USD	92
2014-10-01 to 2014-12-31	2,086,202	USD	92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	438,991	USD	92
2014-10-01 to 2014-12-31	13,664	USD	92

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-53,184	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	76,856	USD	92
2014-10-01 to 2014-12-31	2,539,994	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	257,216	USD	92
2014-10-01 to 2014-12-31	3,415,473	USD	92

Inspect the source

Entity: ARROWHEAD PHARMACEUTICALS, INC. / CIK 0000879407
Captured: 2026-09-20T05:01:27.924Z
SEC response SHA-256: df8855dae0055b71bd49c85d7ebc47f72ea6d71536d6bfd857bed2fe95364863

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000879407.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))